Clinic biz US Stem Cell reports SEC subpoena, adding to uncertainty on its future - The Niche
The last few years for the publicly-traded stem cell clinic biz, US Stem Cell, Inc., which goes by the ticker $USRM, have seemed like a rollercoaster to me as an observer. I can see four main areas of news that to [...]